Gambogic acid is reported to enhance the cytotoxicity of two clinically popular anti-cancer drugs, docetaxel and adriamycin in MCF-7/Adm cells via inhibition of ABCB1 through its protein degradation by proteasome pathway [231]. The gene discussed is ABCB1; the disease is cancer.